In September 2023, researchers from Brigham and Women’s Hospital at Harvard Medical School (Divisions of Cardiac Surgery and Cardiovascular Medicine) and the Washington University School of Medicine (Division of Cardiac Surgery) examined the incidence and outcomes in patients receiving procedural readmissions after transcatheter aortic valve replacement (TAVR). The complete manuscript by Paige Newell, Hoda Javadikasgari,…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Sponsored Links
When 96% of your readmissions are non-cardiac…out of 1092 patients. That’s fantastic.
TAVR is an elegant procedure and offers sufferers a new opportunity to enjoy life.
Great paper.